High prevalence of hepatitis C virus subtypes 4c and 4d in Malaga (Spain): phylogenetic and epidemiological analyses

Nieves Fernández-Arcás1, Juan López-Siles, Sofia Trapero

  • 1Immunology Service, Carlos Haya Regional University Hospital, Malaga, Spain.

Journal of Medical Virology
|September 26, 2006
PubMed

Insights

Hepatitis C virus (HCV) genotype 4, particularly subtypes 4c and 4d, shows a significant prevalence in Malaga, Spain. This study highlights the spread of these HCV subtypes among both intravenous drug users and non-users in the region.

Area of Science:

  • Hepatology
  • Virology
  • Epidemiology

Background:

  • Hepatitis C virus (HCV) is a primary cause of chronic hepatitis, potentially leading to liver cirrhosis and hepatocellular carcinoma.
  • HCV exhibits high genetic variability, resulting in classification into six major clades.
  • Understanding HCV genotype distribution is crucial for effective treatment and public health strategies.

Purpose of the Study:

  • To investigate the distribution of HCV genotypes in Malaga, southern Spain.
  • To characterize the prevalence and subtypes of HCV genotype 4 in the study population.
  • To analyze the epidemiological and phylogenetic features of HCV-4c and HCV-4d subtypes.

Main Methods:

  • A commercial HCV genotyping procedure was applied to 678 patients.
  • HCV-4 subtype distribution was analyzed in 69 patients.
  • Sequencing of the non-structural 5B gene (393 bp) was performed on 36 HCV-4c/4d patients.
  • Phylogenetic analysis was used to distinguish between HCV-4c and HCV-4d subtypes.

Main Results:

  • HCV genotype 4 showed a high prevalence (10.2%) in Malaga.
  • HCV-4 subtypes 4c/4d were the most prevalent (76.8% of HCV-4 cases).
  • Phylogenetic analysis clearly distinguished between HCV-4c and HCV-4d subtypes.
  • HCV-4c/4d infections were found in both intravenous drug users (69%) and non-intravenous drug users (31%).

Conclusions:

  • HCV genotype 4, particularly subtypes 4c and 4d, is prevalent in Malaga, southern Spain.
  • These subtypes are circulating among diverse populations, including intravenous drug users and non-users.
  • Phylogenetic and epidemiological data suggest the ongoing extension of HCV-4c and -4d subtypes in the Malaga area.